Compensated vs. Decompensated Dengue Shock Syndrome
The critical distinction is blood pressure: compensated dengue shock syndrome maintains normal blood pressure through compensatory mechanisms (tachycardia, vasoconstriction) despite plasma leakage and hypovolemia, while decompensated shock presents with hypotension (systolic BP <90 mmHg in adults) indicating cardiovascular collapse.
Clinical Differentiation
Compensated Dengue Shock Syndrome
In compensated shock, children maintain adequate blood pressure through physiologic compensation, but show clear signs of impaired perfusion 1:
- Pulse pressure: 10-20 mmHg (moderate shock) or <10 mmHg (severe shock)
- Perfusion signs: Prolonged capillary refill time (>2-3 seconds), cool extremities, skin mottling, weak peripheral pulses
- Vital signs: Tachycardia, normal or slightly decreased blood pressure
- Mental status: Restlessness, anxiety, or mild lethargy
- Urine output: Decreased (<0.5 mL/kg/hour in adults, <1 mL/kg/hour in children)
Decompensated (Hypotensive) Dengue Shock Syndrome
Decompensated shock represents failure of compensatory mechanisms with frank hypotension 1, 2:
- Blood pressure: Systolic BP <90 mmHg in adults; age-inappropriate hypotension in children
- Pulse pressure: Often unmeasurable or <10 mmHg
- Perfusion signs: Profound—cold, clammy extremities, peripheral cyanosis, absent peripheral pulses
- Mental status: Altered consciousness, obtundation, or coma
- Cardiovascular collapse: Imminent or present
Critical Management Implications
The distinction has profound treatment implications. Children presenting with compensated shock require aggressive fluid resuscitation (20 mL/kg boluses) but may stabilize without vasopressors, while those with decompensated shock need immediate fluid resuscitation PLUS early vasopressor support (dopamine or epinephrine) as cardiovascular collapse is imminent 1, 2.
Fluid Resuscitation Strategy
For severe dengue shock (pulse pressure <10 mmHg), colloid solutions show benefit over crystalloids 1. However, for moderate shock (pulse pressure 10-20 mmHg), crystalloids and colloids produce similar outcomes, making crystalloids first-line in most cases 1.
A critical pitfall: The FEAST trial demonstrated that in resource-limited settings without access to mechanical ventilation and inotropic support, aggressive fluid boluses in children with "severe febrile illness" (not frank shock) increased mortality 3, 4. This underscores the importance of accurate shock classification—compensated shock benefits from aggressive fluids, but pre-shock states without clear perfusion abnormalities may not.
Vasopressor Timing
For decompensated shock or compensated shock not responding to initial 40-60 mL/kg fluid resuscitation, initiate dopamine or epinephrine immediately 1, 2. Delay in vasopressor therapy significantly increases mortality risk 2. Peripheral inotropic support can be started if central access is delayed 2.
Monitoring for Transition
Children with compensated shock can rapidly deteriorate to decompensated shock. Reassess after every fluid bolus 4. Stop fluid resuscitation if hepatomegaly or pulmonary rales develop—these indicate fluid overload requiring diuretics and inotropic support rather than additional fluids 2.
Prognostic Significance
Risk factors for progression from compensated to profound/recurrent shock include: younger age, earlier disease presentation, higher pulse rate, higher temperature, higher hematocrit, and worse hemodynamic status at presentation (particularly in females) 5. These patients require intensive monitoring and may benefit from early colloid use in severe cases (pulse pressure <10 mmHg) 1.
The key clinical principle: blood pressure is maintained until late in pediatric shock due to compensatory mechanisms, so normal blood pressure does not exclude shock—once hypotension develops, cardiovascular collapse follows rapidly 2. Therefore, recognize and treat compensated shock aggressively before decompensation occurs.